Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1223573-41-8

Post Buying Request

1223573-41-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1223573-41-8 Usage

General Description

Tert-butyl 1-oxa-6-azaspiro[3,3]heptane-6-carboxylate is a compound with a complex molecular structure. It consists of a tert-butyl group attached to a 1-oxa-6-azaspiro[3,3]heptane-6-carboxylate moiety. tert-butyl 1-oxa-6-azaspiro[3,3]heptane-6-carboxylate is a spirocyclic heterocycle, containing oxygen and nitrogen atoms in its ring structure. It is often used as a building block for the synthesis of various organic compounds, and it may have potential applications in the pharmaceutical and agrochemical industries. Due to its molecular complexity and specific structural features, tert-butyl 1-oxa-6-azaspiro[3,3]heptane-6-carboxylate requires careful handling and storage, as well as precise analytical techniques for its characterization and identification.

Check Digit Verification of cas no

The CAS Registry Mumber 1223573-41-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,3,5,7 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1223573-41:
(9*1)+(8*2)+(7*2)+(6*3)+(5*5)+(4*7)+(3*3)+(2*4)+(1*1)=128
128 % 10 = 8
So 1223573-41-8 is a valid CAS Registry Number.

1223573-41-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H57040)  6-Boc-1-oxa-6-azaspiro[3.3]heptane, 96%   

  • 1223573-41-8

  • 250mg

  • 3889.0CNY

  • Detail
  • Alfa Aesar

  • (H57040)  6-Boc-1-oxa-6-azaspiro[3.3]heptane, 96%   

  • 1223573-41-8

  • 500mg

  • 6483.0CNY

  • Detail

1223573-41-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 1-oxa-6-azaspiro[3.3]heptane-6-carboxylate

1.2 Other means of identification

Product number -
Other names 1-Oxa-6-azaspiro[3.3]heptane-6-carboxylic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1223573-41-8 SDS

1223573-41-8Relevant articles and documents

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

-

Paragraph 0889; 0890, (2017/04/04)

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

BICYCLIC PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS

-

Page/Page column 80-81, (2011/06/16)

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1223573-41-8